Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
KN · 10-Q filed July 28, 2026

KN earnings analysis

What we found in KN's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Knowles posted a strong Q2: revenue grew 14.3% year over year to $166.8 million, gross margin rose 320 basis points to 44.7%, and GAAP diluted EPS from continuing operations increased to $0.21 from $0.09. Precision Devices led growth with 25.2% revenue expansion, while MSA modestly grew revenue and retained a 40.3% adjusted EBIT margin. The principal offset is cash conversion: first-half adjusted free cash flow dropped $38.1 million year over year to $19.8 million amid working-capital usage and elevated capacity-expansion capex; the filing contains no updated revenue or EPS guidance.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue accelerated sequentially and year over year
Q2 revenue was $166.8 million, up $20.9 million (14.3%) from $145.9 million a year earlier and up $13.7 million (8.9%) from Q1 2026 revenue of $153.1 million.
Margins expanded materially
GAAP gross margin expanded to 44.7% from 41.5% a year ago and 43.8% in Q1 2026. GAAP EBIT margin rose to 14.6% from 9.5% year over year, supported by volume, pricing, utilization, and the absence of the prior-year $3.6 million impairment.
EPS more than doubled year over year
GAAP diluted EPS from continuing operations increased to $0.21 from $0.09 a year earlier and $0.11 in Q1 2026; non-GAAP diluted EPS was $0.33, up from $0.24.
Precision Devices was the growth engine
Precision Devices delivered $98.3 million of revenue, up $19.8 million (25.2%), while adjusted EBIT increased to $20.3 million from $13.9 million and adjusted margin rose to 20.7% from 17.7%.
MSA held growth and strong profitability
MedTech & Specialty Audio revenue increased to $68.5 million from $67.4 million, while adjusted EBIT rose to $27.6 million from $26.1 million and adjusted margin reached 40.3%.
Substantial repurchase capacity remains
The company has $106.5 million remaining under its repurchase authorization after repurchasing $22.5 million, or 692,369 shares, in the first six months of 2026.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Cash conversion weakened sharply
Six-month adjusted free cash flow fell to $19.8 million, or 6.2% of revenue, from $57.9 million, or 20.8%, a year earlier. Management attributed the decline to working-capital investment, loss of a prior-year customer prepayment, and higher capex.
Higher capex and working-capital use pressure cash
Six-month operating cash flow declined to $27.5 million from $37.7 million while capital expenditures increased to $17.3 million from $9.1 million, reflecting PD capacity expansion.
Ceramic transfer costs and mix remain headwinds
Q2 production-transfer costs in the ceramic-capacitor business were $0.8 million versus $0.2 million a year ago; management also cited unfavorable product mix and increased transfer costs as COGS headwinds.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $55 Operating expenses $30 Left as operating profit $15
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$0.21
Gross margin
44.7%
Operating margin
14.6%
Segment
Precision Devices revenue: $98.3 million, up $19.8 million (25.2%) year over year.
Segment
MedTech & Specialty Audio revenue: $68.5 million, up $1.1 million (1.6%) year over year.
Guidance

What they said about what is next.

The 10-Q provides no revenue or EPS guidance. Management expects 2026 capital expenditures to be approximately 5% of revenue, driven by Precision Devices capacity expansion, including the specialty-film product line.

How we read the filing overall

The filing reads better than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · April 28, 2026
Knowles reported Q1 2026 revenue of $153.1 million, up $20.9 million or 15.8% versus Q1 2025, with gross profit of $67.1 million and gross margin expanding to 43.8% from 40.3% year-over-year. GAAP diluted EPS from…
10-Q · April 29, 2025
Knowles reported Q1 2025 revenue of $132.2 million, roughly flat (-$1.1M) versus Q1 2024 ($133.3M), but swung to a net loss of $2.0 million (diluted EPS $(0.02)) compared with net earnings of $2.5 million (EPS $0.03) in…
10-K · February 13, 2025
Knowles positions itself as a specialty electronic components leader focused on higher-value PD (capacitors, RF filters) and MSA (balanced armature speakers, microphones) markets and completed the divestiture of its…
10-Q · July 31, 2024
Knowles reported Q2 revenue of $204.7M, up $31.7M (+18.3%) versus $173.0M a year ago, but reported a large GAAP net loss and non-cash goodwill impairment. Management recorded a $249.4M goodwill impairment related to the…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing KN makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever